World Melioidosis Congress 2010

描述(由申请人提供)： 类鼻疽病是一种在世界热带和亚热带地区流行的疾病，澳大利亚北部和东南亚是高度流行的疾病。在过去的十年里，类鼻疽病的研究激增，很大程度上是因为假鼻疽伯克霍尔德氏菌被认为是世界上许多热带和亚热带地区的一种新的病原体，也被列为具有生物防御重要性的精选病原体。目前的迹象表明，这种兴趣的增加将是自我维持的，并随着时间的推移而持续。尽管研究激增，但世界类鼻疽会议(WMC)目前是世界上唯一定期安排的类鼻疽会议。这项申请的具体目的是确保用于旅行、住宿和注册的资金，使至少10-12名研究人员--主要是来自世界欠发达地区的实习生、年轻研究人员和代表性不足的少数族裔或科学家--能够参加将于2010年11月30日至12月3日在澳大利亚昆士兰州汤斯维尔举行的第六届WMC(也称为WMC2010)。WMC2010的主要目标是将250-300名科学家、医生、博士后研究员和学生聚集在一起，讨论学术实验室研究的新发现，重点探讨如何将其转化为现实环境，并促进美国和欧洲(进行大量基础研究的地区)、亚太地区和其他类鼻疽流行地区的小组之间发展强有力的合作。有机会与致力于测试控制和预防类鼻疽病的新想法和试剂的发展中国家的科学家/机构建立合作关系，这一机会既重要又至关重要。大会的主要主题包括流行病学、环境和类鼻疽病、临床和实验室诊断学、免疫学和疫苗开发、生物防御和治疗学。 项目说明： 类鼻疽病是一种罕见但严重的具有生物防御意义的新兴疾病。请拨资金协助研究人员--主要是见习生、青年研究人员和代表不足的少数群体或发展中国家科学家--出席在澳大利亚汤斯维尔举行的2010年世界类梅毒会议。这次会议将促进在美国和欧洲以及亚太地区和其他类鼻疽流行地区的小组之间开展强有力的合作，美国和欧洲是进行大量基础研究的地方。

DESCRIPTION (provided by applicant): Melioidosis is a disease prevalent to tropical and subtropical regions of the world, with Northern Australia and SE Asia being highly endemic. The last decade saw a surge in melioidosis research largely because the etiologic agent Burkholderia pseudomallei is considered an emerging pathogen in many tropical and subtropical regions of the world and also listed as a Select Agent of biodefense importance. Current indications are that this increase in interest will be self-sustaining and continue over time. Despite the surge in research the World Melioidosis Conference (WMC) is at the moment the only regularly scheduled melioidosis conference anywhere in the world. The specific aim of this application is to secure funds for travel, accommodation and registration to enable at least 10-12 researchers - mostly trainees, young investigators and underrepresented minorities or scientists from underdeveloped regions of the world - to attend the 6th WMC (also known as WMC2010) that will be held in Townsville, Queensland, Australia, from November 30 to December 3, 2010. The main objectives of WMC2010 will be to bring together 250-300 scientists, physicians, postdoctoral research associates and students to discuss new findings from research academic laboratories, to focus on ways in which this can be translated into real-world settings, and to facilitate the development of strong collaborations between groups in the United States and Europe where much of the fundamental research is conducted, and the Asian-Pacific region and other areas where melioidosis is endemic. The opportunity to establish collaborations and engage scientists/institutions from developing countries that are committed to the testing of novel ideas and reagents to control and prevent melioidosis is both important and essential. The key themes of the congress include epidemiology, the environment and melioidosis, clinical and laboratory diagnostics, immunology and vaccine development, biodefense, and therapeutics. Project Narrative: Melioidosis is a rare but serious emerging disease of biodefense significance. Funds are requested to facilitate researcher - mostly trainee, young investigators, and underrepresented minorities or developing world scientists - attendance of the World Melioidosis Conference 2010 in Townsville, Australia. This conference will facilitate the development of strong collaborations between groups in the United States and Europe where much of the fundamental research is conducted, and the Asian-Pacific region and other areas where melioidosis is endemic.